Partnering for scientific leadership Biotech Unit ...

1 For more information please go to: for scientific leadership Biotech unit Partnering TeamEarly-Stage opportunities (up to and including Phase I) Our Biotech Partnering teams are focused on sourcing early-stage opportunities that are a strategic fit with our therapy area portfolio and innovative scientific Development LeadershipReg SeetoVP, Biotech Partnering & SrinivasanVP, scientific Partnering & & MetabolicDiseases (CVMD)Eric VictoryVP, Biotech Partnering & BrickmannDirector, scientific Partnering & Inflammation& Autoimmunity (RIA)Eric ParadiseSenior Director, Biotech Partnering & TaylorDirector, scientific Partnering & TsangSenior Director, Biotech Partnering & DahlExecutive Director, scientific Partnering & Collaborations(Government/University/Non -profit)Jarrod BorkatSenior Director, Biotech Partnering & WangDirector, scientific Partnering & Spin-outsJung LeeHead of Tech, BPD & ComleyDirector, scientific Partnering & SrinivasanVP, scientific Partnering & KimDirector, Biotech Partnering & WoodwardAssociate Director, Biotech Partnering & OliverDirector, Partnering & ShankarGlobal Business Development, Neuroscience areaSmall MoleculeInnovative Medicines and Early Development (IMED)BiologicsMedImmunePartnering for scientific leadership Global Product & Portfolio Strategy (GPPS) Mid to late-stage opportunities (Phase II & beyond) Specialist Search & Evaluation teams are embedded in our GPPS group aligned to our main therapy areas across small molecules and biologics.

2 For Oncology, the team oversees opportunities where there is the potential to fast-track from Phase I to Phase & MetabolicDiseases (CVMD)Business Development Operations LeadershipOncologyAlliance & IntegrationManagementInfection, Neuroscience& Gastrointestinal (ING)Respiratory, Inflammation& Autoimmunity (RIA)Personalised Healthcare (PHC)Mike DiemVP and Head, Corporate GutchExecutive Director, Corporate TrainerVP, Corporate Business Development Operations provides world-class capabilities in due diligence and creative deal-making, including personalised healthcare and Alliance & Integration Strategy and Corporate Development sets the long-term direction of the company to maintain our financial and commercial competitiveness, including M&A, externalisation opportunities, global opportunities in new areas of business, and geographic opportunities coming from key markets or areaDonald DwyerDirector, GradyVP, Business Development MojasVP, Oncology Evaluation and Early TwaitVP, Alliance and Integration GallantGlobal Head, ING Business CantelloHead, RIA SchottHead, GrepinetExecutive Director.

3 Corporate & Evaluation TeamTyrell RiversExecutive Director, Corporate UechiVP, Regional Business Development, Asia